Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Desensitization and Tachyphylaxis

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...

Transducer Mechanism: G Protein–Coupled Receptors

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...

Dosage Regimens: Partial Pharmacokinetic Parameters

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...

Pharmacodynamic Responses: Different Types

Pharmacodynamic Responses: Different Types

Pharmacodynamics is the scientific study of a drug's biochemical or physiological influence on the body. It categorizes responses into continuous, discrete (or categorical), and time-to-event outcomes. Continuous responses yield numerical values within a certain range, such as blood pressure readings and blood glucose levels, gauging the efficacy of antihypertensive and antidiabetic drugs. Discrete responses can be binary, indicating whether a drug has an effect or not, or ordinal, exemplifying...

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

Pharmacodynamics: Overview and Principles

Pharmacodynamics: Overview and Principles

Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Post-surgical hemifrontal anhidrosis].

Revista espanola de anestesiologia y reanimacion·2014

Same journal

Extra-ocular muscle haematoma masquerading uveal prolapse post blunt trauma to the eye: A case report.

Archivos de la Sociedad Espanola de Oftalmologia·2026

Same journal

Multifocal intraocular lenses in refractive lens exchange: Guidelines to optimize their use and indications.

Archivos de la Sociedad Espanola de Oftalmologia·2026

Same journal

The Effect of Pre- and Perioperative Anxiety on Cardiovascular Parameters and Intraocular Pressure of Patients Awaiting Phacoemulsification Surgery.

Archivos de la Sociedad Espanola de Oftalmologia·2026

Same journal

Management of central corneal opacities using manual and femtosecond laser-assisted rotational anterior lamellar autokeratoplasty: A descriptive case series.

Archivos de la Sociedad Espanola de Oftalmologia·2026

Same journal

Evaluation of the anterior hyaloid using intraoperative optical coherence tomography: a key strategy in complex cataract surgery.

Archivos de la Sociedad Espanola de Oftalmologia·2026

Same journal

Unilateral ocular hypertension secondary to frontal mucocele with orbital extension.

Archivos de la Sociedad Espanola de Oftalmologia·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 10, 2026

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

Published on: April 25, 2012

[Pharmacological pseudo-Fuchs].

C Sevillano Torrado¹, E Lugo Adán, E Viso Outeiriño

¹Servicio de Oftalmología, Hospital Do Salnés, Vilagarcía de Arousa, Pontevedra, España. seviojos@hotmail.com

Archivos De La Sociedad Espanola De Oftalmologia

|June 18, 2013

Summary

This summary is machine-generated.

Travoprost, a glaucoma medication, can rarely cause unilateral iridis hyperpigmentation and anterior uveitis. This case highlights the importance of considering drug side effects in differential diagnosis, even with iris heterochromia.

More Related Videos

Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model

Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model

Published on: April 28, 2023

Related Experiment Videos

Last Updated: May 10, 2026

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

Published on: April 25, 2012

Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model

Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model

Published on: April 28, 2023

Area of Science:

Ophthalmology
Pharmacology

Background:

Glaucoma management often involves prostaglandin analogs like travoprost.
Unilateral ocular inflammation and iris pigmentation changes are potential adverse effects.

Observation:

A patient presented with unilateral iridis hyperpigmentation and anterior uveitis.
The condition was initially suspected to be Fuchs heterochromic iridocyclitis.

Findings:

Travoprost was identified as the causative agent for both anterior uveitis and unilateral iridis hyperpigmentation.
Iris heterochromia presented a diagnostic challenge, mimicking other conditions.

Implications:

This case underscores the importance of a thorough medication history in diagnosing ocular inflammation.
Ophthalmologists should consider drug-induced uveitis and hyperpigmentation in patients using travoprost.
Accurate diagnosis is crucial to avoid misclassification and ensure appropriate management of ocular side effects.